Cancer researcher Orazio Vittorio says a modified antioxidant called catechin can kill 50 per cent of the cells from neuroblastoma cancers within three days in laboratory studies.

On Friday night he was awarded the Kid's Cancer Project Award in the NSW Premier's Awards for Outstanding Cancer Research, which will give him $25,000 to put towards developing potentially life-saving treatment from his research.

Neuroblastoma is the most common cancer to strike infants, and has the lowest survival rate of all childhood cancers.

Catechin, extracted from green tea, is thought to be a promising cancer treatment, but its instability when it enters the body limits its effectiveness.

Dr Vittorio worked with a team of chemists to modify the catechin into a more stable form.

"The modified form of catechin is effective at destroying neuroblastoma cells that are highly resistant to conventional chemotherapy, yet has minimal effects on normal cells," said Dr Vittorio, from the Children's Cancer Institute Australia and the Lowy cancer research centre at UNSW. "Now I'll be able to build on this research and work towards an effective therapy for aggressive neuroblastoma".

Dr Vittorio, who survived kidney cancer five years ago, said that as his as-yet unpublished results were preliminary, he did not know how long it would take to develop treatments. "But as a father of a boy who is two years old and a cancer survivor, I'm doing my best to win this," he said.

His was one of 10 awards valued at $395,000. Premier Barry O'Farrell presented the award for outstanding cancer researcher to Professor John Thompson for his work in melanoma research.

David Currow, the chief executive of the Cancer Institute and Chief Cancer Officer, said as we learnt more about cancer, it was becoming clear no single solution would be found.

"Through our investment in research excellence we are enabling our talented researchers to come up with a wide range of innovative and practical solutions that make a very real difference," he said.